OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study
Matteo Piga, Elisabetta Chessa, Eric F. Morand, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 6, pp. e441-e449
Open Access | Times Cited: 29
Matteo Piga, Elisabetta Chessa, Eric F. Morand, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 6, pp. e441-e449
Open Access | Times Cited: 29
Showing 26-50 of 29 citing articles:
Disease activity assessment in systemic lupus erythematosus
Angela E. Lin, Ambika Wakhlu, Kathryn Connelly
Frontiers in Lupus (2024) Vol. 2
Open Access
Angela E. Lin, Ambika Wakhlu, Kathryn Connelly
Frontiers in Lupus (2024) Vol. 2
Open Access
Framework for Implementing Treat-To-Target in Systemic Lupus Erythematosus Routine Clinical Care: Consensus Statements from An International Task Force
Matteo Piga, Ioannis Parodis, Zahi Touma, et al.
(2024)
Closed Access
Matteo Piga, Ioannis Parodis, Zahi Touma, et al.
(2024)
Closed Access
Defining the physician global assessment threshold equivalent to remission in patients with systemic lupus erythematosus
Johanna Mücke, Christina Düsing, Tim Filla, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 6, pp. 1649-1655
Closed Access | Times Cited: 1
Johanna Mücke, Christina Düsing, Tim Filla, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 6, pp. 1649-1655
Closed Access | Times Cited: 1
Residual disease activity and treatment intensification in systemic lupus erythematosus: A cross-sectional study to quantify the need for new therapies
Ourania Gioti, Katerina Chavatza, Myrto Nikoloudaki, et al.
Lupus (2022) Vol. 31, Iss. 14, pp. 1726-1734
Closed Access | Times Cited: 2
Ourania Gioti, Katerina Chavatza, Myrto Nikoloudaki, et al.
Lupus (2022) Vol. 31, Iss. 14, pp. 1726-1734
Closed Access | Times Cited: 2
Patient and Physician Global Assessments of Disease Status in Systemic Sclerosis
Laura Ross, Mandana Nikpour, Julie Daoust, et al.
Arthritis Care & Research (2022) Vol. 75, Iss. 7, pp. 1443-1451
Open Access | Times Cited: 2
Laura Ross, Mandana Nikpour, Julie Daoust, et al.
Arthritis Care & Research (2022) Vol. 75, Iss. 7, pp. 1443-1451
Open Access | Times Cited: 2
Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist’s judgement?
Irene Altabás-González, Íñigo Rúa‐Figueroa, Francisco Rubiño, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 1, pp. 72-78
Open Access
Irene Altabás-González, Íñigo Rúa‐Figueroa, Francisco Rubiño, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 1, pp. 72-78
Open Access
